XenoPort (XNPT) February put volatility at 138 into FDA deadline
Tweet Send to a Friend
XenoPort (Nasdaq: XNPT) is recently down $1.30 to $18.60. The FDA deadline for approval of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
